Komo Terry, Munywoki Patrick K, Carvalho Maria da Gloria, Auko Joshua, Ouma Alice, Audi Allan, Agogo George O, Omondi Daniel, Odoyo Arthur, Odiembo Herine, Wamola Newton, Osita Mike, Onyango Clayton, Lucchi Naomi, Munyua Peninah, Herman-Roloff Amy, Larson Shanda, Chochua Sopio, Pimenta Fabiana C, Bigogo Godfrey, Verani Jennifer R
Emerg Infect Dis. 2025 Feb;31(2):345-349. doi: 10.3201/eid3102.241652.
Use of 10-valent pneumococcal conjugate vaccine in Kenya has led to substantial reductions in vaccine-type pneumococcal carriage and invasive pneumococcal disease. However, analysis of recent surveillance data indicates an outbreak of vaccine-type serotype 1 in 2023 in Kibera, Kenya. Continued monitoring of invasive pneumococcal disease in Kenya is warranted.
在肯尼亚使用10价肺炎球菌结合疫苗已导致疫苗型肺炎球菌携带率和侵袭性肺炎球菌疾病大幅下降。然而,对近期监测数据的分析表明,2023年在肯尼亚基贝拉爆发了疫苗型1血清型疫情。有必要继续监测肯尼亚的侵袭性肺炎球菌疾病。